$202.08
1.200.60%
At close: -
$201.11
-0.97-0.48%
After Hours: 7:48 PM EDT
AbbVie reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AbbVie using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-01-31 | $2.16 | $2.26 | -4.42 % |
Q3 | 2024-10-30 | $3.00 | $2.92 | 2.74 % |
Q2 | 2024-07-25 | $2.65 | $2.57 | 3.11 % |
Q1 | 2024-04-26 | $2.31 | $2.23 | 3.59 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-01-31 | $15.10B | $14.83B | 1.83 % |
Q3 | 2024-10-30 | $14.46B | $14.28B | 1.26 % |
Q2 | 2024-07-25 | $14.46B | $14.03B | 3.08 % |
Q1 | 2024-04-26 | $12.31B | $11.92B | 3.27 % |
AbbVie (ABBV) is scheduled to report earnings on April 25, 2025. The last reported earnings were for reported on January 31, 2025 for Q4.
The Actual EPS was $2.16, which missed the estimate of $2.26.
The Actual Revenue was $15.1B, which beat the estimate of $14.8B.
Browse earnings estimates, EPS, and revenue on all stocks.